More than a simple shift from indulgence to health, it's a move toward "smart consumption": Fewer choices Higher scrutiny Stronger demand for function and value In our latest article, we unpack how GLP-1 is redefining shopper behavior and what it means for FMCG brands
GLP-1 receptor agonists mimic incretin hormones, suppressing appetite, slowing gastric emptying, and improving insulin sensitivity
Understanding this science helps patients appreciate why Semaglutide is so effective for sustainable weight loss
So, electrolyte-enhanced waters, functional beverages, even hydration powders, are some of the newest technologies that were tracking for our clients. Reduced appetite, reduced spending One area many CPG companies have been watching is the data that correlates GLP-1 use with reduced spending on food, due to smaller appetites while taking the drugs
These were treatment-resistant cases
And the weight comes back, often faster than before